Ocular safety of intravitreal clindamycin hydrochloride released by PLGA implants.

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorCunha, Gabriella Maria Fernandes-
Autor(es): dc.creatorFialho, Sílvia Ligório-
Autor(es): dc.creatorSilva, Gisele Rodrigues da-
Autor(es): dc.creatorCunha Júnior, Armando da Silva-
Autor(es): dc.creatorZhao, Min-
Autor(es): dc.creatorCohen, Francine Behar-
Data de aceite: dc.date.accessioned2025-08-21T15:56:21Z-
Data de disponibilização: dc.date.available2025-08-21T15:56:21Z-
Data de envio: dc.date.issued2019-04-17-
Data de envio: dc.date.issued2019-04-17-
Data de envio: dc.date.issued2017-
Fonte completa do material: dc.identifierhttp://www.repositorio.ufop.br/handle/123456789/11060-
Fonte completa do material: dc.identifierhttps://link.springer.com/article/10.1007%2Fs11095-017-2118-2-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/1028005-
Descrição: dc.descriptionBackground Drug ocular toxicity is a field that requires attention. Clindamycin has been injected intravitreally to treat ocular toxoplasmosis, the most common cause of eye posterior segment infection worldwide. However, little is known about the toxicity of clindamycin to ocular tissues. We have previously showed non intraocular toxicity in rabbit eyes of poly(lactic-co-glycolic acid) (PLGA) implants containing clindamycin hydrochloride (CLH) using only clinical macroscotopic observation. In this study, we investigated the in vivo biocompatibility of CLH-PLGA implants at microscotopic, cellular and molecular levels. Methods Morphology of ARPE-19 and MIO-M1 human retinal cell lines was examined after 72 h exposure to CLH-PLGA implant. Drug delivery system was also implanted in the vitreous of rat eyes, retinal morphology was evaluated in vivo and ex vivo. Morphology of photoreceptors and inflammation was assessed using immunofluorescence and real-time PCR. Results After 72 h incubation with CLH-PLGA implant, ARPE-19 and MIO-M1 cells preserved the actin filament network and cell morphology. Rat retinas displayed normal lamination structure at 30 days after CLH-PLGA implantation. There was no apoptotic cell and no loss in neuron cells. Cones and rods maintained their normal structure. Microglia/macrophages remained inactive. CLH-PLGA implantation did not induce gene expression of cytokines (IL-1β, TNF-α, IL-6), VEGF, and iNOS at day 30. Conclusion These results demonstrated the safety of the implant and highlight this device as a therapeutic alternative for the treatment of ocular toxoplasmosis.-
Formato: dc.formatapplication/pdf-
Idioma: dc.languageen-
Direitos: dc.rightsrestrito-
Palavras-chave: dc.subjectBiocompatibility-
Palavras-chave: dc.subjectClindamycin-
Palavras-chave: dc.subjectOcular toxoplasmosis-
Palavras-chave: dc.subjectToxicity-
Título: dc.titleOcular safety of intravitreal clindamycin hydrochloride released by PLGA implants.-
Aparece nas coleções:Repositório Institucional - UFOP

Não existem arquivos associados a este item.